Name:
Pyracetam tablets p/o 400mg in a cell.pack No. 10×2
Description:
Coated tablets, white, with a biconvex surface. The main active ingredient Piracetam Release form Tablets Dosage 400 mg Pharmacological action Piracetam is a nootropic agent that improves cognitive functions. It has an effect on the central nervous system in various ways: it changes the rate of propagation of excitation in the brain, improves metabolic conditions for neuronal plasticity. It improves microcirculation by affecting the rheological characteristics of the blood and does not cause a vasodilating effect. Piracetam helps to restore cognitive abilities after cerebral dysfunction due to hypoxia, intoxication or trauma. Reduces the severity and duration of vestibular nystagmus. Piracetam is used in the treatment of cortical myoclonus as monotherapy or in combination with antimyoclonic agents. Indications Piracetam is indicated for the symptomatic treatment of memory or intellectual impairment in the absence of a diagnosis of dementia (symptomatic treatment of chronic psychoorganic syndrome). Piracetam may reduce the manifestations of cortical myoclonus. To determine the effect of piracetam in a patient with cortical myoclonus, a trial course of treatment is necessary. Method of administration and doses In the treatment of chronic conditions, piracetam is used orally (before meals), washed down with plenty of water (100–200 ml), starting with 1200 mg (400 mg 3 times a day), and adjusting the dose to 2400 mg, sometimes up to 3200 mg or more per day. The therapeutic effect in these cases is noted, as a rule, 2-3 weeks after the start of treatment. Subsequently, the dose is reduced to 1200-1600 mg (400 mg 3-4 times a day). The course of treatment with piracetam lasts from 2–3 weeks to 2–6 months. If necessary, it is repeated after 6-8 weeks. In the symptomatic treatment of chronic psychoorganic syndrome, depending on the severity of symptoms, 1200-2400 mg / day is prescribed, and during the first week – 4800 mg / day. With cortical myoclonus, treatment begins with 7200 mg / day. If necessary, every 3-4 days, the dose is increased by 4800 mg / day until a maximum dose of 24,000 mg / day is reached in 2-3 doses. In the treatment of cortical myoclonus, it is recommended to use another drug with a high content of piracetam. A daily dose of 24,000 mg of piracetam is prescribed daily for 3 days. In case of low response or no response on the third day of treatment, the appointment of piracetam is extended to 7 days. In case of low response or no response on the seventh day of therapy, treatment should be discontinued. If a daily dose of 24,000 mg has been effective, begin to reduce the dose by 1200 mg every 2 days until the onset of myoclonus. This scheme allows you to choose the average therapeutic dose of piracetam. During the selection of the dose of piracetam, changing the doses of other antimyoclonic agents is not carried out. In the case of a positive effect from taking piracetam, it is advisable to consider the possibility of reducing the doses of antimyoclonic agents. In the treatment of cortical myoclonus, treatment is continued throughout the entire period of the disease. Every 6 months, an attempt should be made to reduce the dose or stop piracetam by gradually reducing the dose by 1200 mg every 2 days in order to prevent an attack. Since piracetam is excreted from the body by the kidneys, when prescribing the drug to patients with renal insufficiency and elderly patients, the dose should be adjusted depending on the CC. CC for men can be calculated based on the content of serum creatinine using the following formula: CC (ml / min) u003d (140 – age) body weight (kg) / 72 serum creatinine (mg / dl). For women: the result of the calculation should be multiplied by 0.85. Patients with renal insufficiency require dose adjustment of the drug in accordance with the following scheme. Renal failure – CC (ml / min) – Dose and frequency of use Norm – > 80 – Usual dose Mild – 50-79 – 2/3 of the usual dose in 2-3 doses Moderate – 30-49 – 1/3 of the usual dose in 2 doses Severe degree – < 30 - 1/6 of the usual dose, once Piracetam is contraindicated in end-stage chronic renal failure. In elderly patients, the dose is adjusted in the presence of renal failure; with prolonged therapy, it is necessary to monitor the functional state of the kidneys. Patients with impaired liver function dose adjustment is not required. For patients with impaired function of both the kidneys and the liver, the drug is prescribed in the same way as for patients with only impaired renal function. Use during pregnancy and lactation The use of the drug during pregnancy is contraindicated. If necessary, use during lactation should decide on the termination of breastfeeding. Influence on the ability to drive a car and potentially dangerous mechanisms During the period of treatment, care must be taken when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions. PrecautionsRecommended constant monitoring of indicators of kidney function (especially in patients with chronic renal failure) - residual nitrogen and creatinine, and in patients with liver disease - the functional state of the liver. In the treatment of patients with cortical myoclonus, abrupt discontinuation of the drug should be avoided (risk of recurrence of seizures). In case of sleep disturbances, it is recommended to cancel the evening intake by adding this dose to the daytime intake. Due to the effect of piracetam on platelet aggregation, caution should be exercised when prescribing piracetam to patients with risk factors for bleeding: peptic ulcer of the stomach and duodenum, previous intracerebral hemorrhage, recent surgery (including dental), taking anticoagulants or antiplatelet agents, in including low dose aspirin. Penetrates through the filtering membranes of hemodialysis machines. Application in children. The use of the drug in children under 18 years of age is not recommended due to the lack of adequate data. Interaction with other agents: When used simultaneously with thyroid hormones, there have been reports of confusion, irritability and sleep disturbance. According to a study of patients with recurrent venous thrombosis, piracetam at a dose of 9.6 g / day increases the effectiveness of indirect anticoagulants. Taking piracetam at a dose of 20 g / day for 4 weeks did not change the maximum serum concentration of antiepileptic drugs (carbamazepine, phenytoin, phenobarbital, valproate) in patients with epilepsy who received piracetam at a stable dose. Co-administration with alcohol did not affect the serum concentration of piracetam, and the concentration of ethanol in the blood serum did not change when taking 1.6 g of piracetam. Contraindications Hypersensitivity, severe renal failure (creatinine clearance less than 20 ml / min), hemorrhagic stroke, psychomotor agitation, agitated depression, Huntington's disease, pregnancy, lactation. With caution: violation of hemostasis, extensive surgical interventions, severe bleeding, hyperthyroidism, epilepsy. Composition Each tablet contains: active substance: piracetam - 400 mg; excipients: povidone K-25; magnesium carbonate basic, light; calcium stearate; potato starch; opadra II white (85G). Composition of Opadry II white (85G): partially hydrolyzed polyvinyl alcohol; titanium dioxide E 171; talc; polyethylene glycol 3350; lecithin (soy). OverdoseSymptoms: increased possible side effects. Treatment: gastric lavage, activated charcoal, symptomatic therapy, hemodialysis is possible (efficiency - 50-60%). There is no specific antidote. Side effects From the nervous system: mental agitation, motor disinhibition, irritability, imbalance, decreased ability to concentrate, anxiety, insomnia or drowsiness, depression, ataxia, dizziness, headache, extrapyramidal disorders (including hyperkinesis), convulsions, tremor, exacerbation of the course of epilepsy, imbalance, confusion, hallucinations. From the side of the cardiovascular system: arterial hypo- or hypertension is possible, in elderly patients, exacerbation of coronary insufficiency, worsening of the course of angina pectoris. On the part of the blood system: blood clotting disorders. From the immune system: the frequency is unknown - anaphylactoid reactions, hypersensitivity. From the digestive system: gastralgia, nausea, vomiting, diarrhea. On the part of the hearing organs: the frequency is unknown - vertigo. Allergic reactions: dermatitis, itching, rash, angioedema. Other: increased sexual activity, weight gain, asthenia. In the event of the above adverse reactions, as well as adverse reactions not listed in these instructions for medical use of the drug, you should consult a doctor. Storage conditions Store in a place protected from moisture and light at a temperature not exceeding 25 ° C. Keep out of the reach of children. Buy Piracetam tablets p/o 400mg No. 10x2
The code | 38329 |
---|---|
Barcode | 4 811 098 001 550 |
Dosage | 400mg |
Active substance | Piracetam |
Manufacturer | Belmedpreparaty RUE, Belarus |
Be the first to review “Piracetam pills p/o 400mg №10×2” Cancel reply
Related products
Improvement of cerebral circulation
$18.00
Improvement of cerebral circulation
$14.00
Improvement of cerebral circulation
$20.00
Reviews
There are no reviews yet.